Ribociclib improved the Survival of breast cancer-Affected Brustkresbs is worldwide the most common cancer in women. Approximately every eighth woman becomes ill in the course of their lives. Most of the risk between the 40’s. and 70. Years of age. In Germany, about 70,000 new cases are registered per year. Of 17,000 women die each